BRD2 and neoplasm: For patients with lower CA 19–9 levels following NAT (responders), the % reduction in CA 19–9 correlated moderately positively with 11 serum and 26 tissue DALs, most of which belonged to the lipid classes TG for serum and phospholipids for tumour tissue.